Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 1,326 - 1,350 of 2,711

«
1
…
52
53
54
55
56
…
109
»

Liquid Biopsy and Precision Medicine Updates in GU

Liquid Biopsy and Precision Medicine Updates in GU

By: Pedro Barata, MD

Bispecific Antibodies in Cancer Care: Actual Reality and Future Projections

Bispecific Antibodies in Cancer Care: Actual Reality and Future Projections

By: Sandip P. Patel, MD

Bispecific Antibodies in Cancer Care: Actual Reality and Future Projections

Bispecific Antibodies in Cancer Care: Actual Reality and Future Projections

By: Sandip P. Patel, MD

Targeted Therapy Updates in HCC and Cholangiocarcinoma

Targeted Therapy Updates in HCC and Cholangiocarcinoma

By: Amit Mahipal, MD

Hepatocellular and Biliary Cancers: Recent advances

Hepatocellular and Biliary Cancers: Recent advances

By: Anthony El-Khoueiry, MD

Hepatocellular and Biliary Cancers: Recent advances

Hepatocellular and Biliary Cancers: Recent advances

By: Anthony El-Khoueiry, MD

Navigating locoregional treatment options in HCC

Navigating locoregional treatment options in HCC

By: Beau Toskich, MD

Ablation with a curative intent in HCC

Ablation with a curative intent in HCC

By: Fred T. Lee, MD

Minimally Invasive to Noninvasive- HOPE 4 LIVER Results

Minimally Invasive to Noninvasive- HOPE 4 LIVER Results

By: Govindarajan Narayanan, MD

Time to Transplant – An important factor in selection of liver directed therapy

Time to Transplant – An important factor in selection of liver directed therapy

By: Jafar Golzarian, MD

Impact of c-TACE on the management of HCC

Impact of c-TACE on the management of HCC

By: Jeff Geschwind, MD

Hepatocellular Cancer and Cholangiocarcinoma Updates

Hepatocellular Cancer and Cholangiocarcinoma Updates

By: Lindsey Davis, MD

Hepatocellular Cancer and Cholangiocarcinoma Updates

Hepatocellular Cancer and Cholangiocarcinoma Updates

By: Lindsey Davis, MD

Irreversible Electroporation in Hepatocellular Carcinomas Adjacent to Critical Anatomical Structures, a Single Centre Experience

Irreversible Electroporation in Hepatocellular Carcinomas Adjacent to Critical Anatomical Structures, a Single Centre Experience

By: Nuran Seneviratne, MA, MBBS

Immunotherapy in HCC

Immunotherapy in HCC

By: Rachna T. Shroff, MD, MS, FASCO

Current role of systemic therapy in HCC

Current role of systemic therapy in HCC

By: Saeed Sadeghi, MD

Role of genomics, molecular biomarkers and AI in HCC therapy

Role of genomics, molecular biomarkers and AI in HCC therapy

By: Sarah White, MD

Cholangiocarcinoma and Hepatocellular Cancer

Cholangiocarcinoma and Hepatocellular Cancer

By: Tom Reske, MD

New Therapies for Squamous Cell and Small Cell Lung Carcinomas

New Therapies for Squamous Cell and Small Cell Lung Carcinomas

By: Alberto Chiappori, MD

State of the Art Radiation in NSCLC

State of the Art Radiation in NSCLC

By: Ana Botero, MD

State of the Art Radiation in NSCLC

State of the Art Radiation in NSCLC

By: Ana Botero, MD

Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy

Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy

By: Ana Velazquez Manana, MD, MSc

Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy

Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy

By: Ana Velazquez Manana, MD, MSc

Small Cell Lung Cancer: 1L and Beyond

Small Cell Lung Cancer: 1L and Beyond

By: Anne Chiang, MD

Small Cell Lung Cancer: 1L and Beyond

Small Cell Lung Cancer: 1L and Beyond

By: Anne Chiang, MD

«
1
…
52
53
54
55
56
…
109
»

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok